A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies

BACKGROUND: Despite new treatment options for hepatocellular carcinomas (HCC) recently, 5-year survival remains poor, ranging from 50 to 70%, which may attribute to the lack of early diagnostic biomarkers. Thus, developing new biomarkers for early diagnosis of HCC, is extremely urgent, aiming to dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feifei, Wang, Ruliang, Li, Qiuwen, Qu, Xueling, Hao, Yixin, Yang, Jingwen, Zhao, Huixia, Wang, Qian, Li, Guanghui, Zhang, Fengyun, Zhang, He, Zhou, Xuan, Peng, Xioumei, Bian, Yang, Xiao, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237304/
https://www.ncbi.nlm.nih.gov/pubmed/28086821
http://dx.doi.org/10.1186/s13000-016-0596-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237304/
https://www.ncbi.nlm.nih.gov/pubmed/28086821
http://dx.doi.org/10.1186/s13000-016-0596-x

Ejemplares similares